Immunic Balance Sheet Health
Financial Health criteria checks 4/6
Immunic has a total shareholder equity of $41.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $64.8M and $23.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$59.07m |
| Equity | US$41.22m |
| Total liabilities | US$23.54m |
| Total assets | US$64.76m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 10VA's short term assets ($63.3M) exceed its short term liabilities ($23.4M).
Long Term Liabilities: 10VA's short term assets ($63.3M) exceed its long term liabilities ($186.0K).
Debt to Equity History and Analysis
Debt Level: 10VA is debt free.
Reducing Debt: 10VA has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 10VA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 10VA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 22.3% each year